Raymond James Trust’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.18M | Buy |
55,200
+2,120
| +4% | +$114K | 0.07% | 235 |
|
|
2024
Q2 | $2.58M | Buy |
53,080
+3,809
| +8% | +$184K | 0.06% | 269 |
|
|
2024
Q1 | $2.39M | Buy |
49,271
+5,382
| +12% | +$263K | 0.06% | 280 |
|
|
2023
Q4 | $2.18M | Sell |
43,889
-52
| -0.1% | -$2.54K | 0.06% | 284 |
|
|
2023
Q3 | $2.36M | Buy |
43,941
+359
| +0.8% | +$19.1K | 0.07% | 231 |
|
|
2023
Q2 | $2.35M | Buy |
43,582
+1,085
| +3% | +$58.4K | 0.07% | 242 |
|
|
2023
Q1 | $2.31M | Buy |
42,497
+8,234
| +24% | +$400K | 0.07% | 230 |
|
|
2022
Q4 | $1.66M | Buy |
34,263
+4,000
| +13% | +$176K | 0.06% | 281 |
|
|
2022
Q3 | $1.15M | Sell |
30,263
-2,032
| -6% | -$90.5K | 0.04% | 340 |
|
|
2022
Q2 | $1.62M | Buy |
32,295
+2,085
| +7% | +$111K | 0.06% | 275 |
|
|
2022
Q1 | $1.55M | Buy |
30,210
+6,561
| +28% | +$339K | 0.05% | 312 |
|
|
2021
Q4 | $1.19M | Buy |
23,649
+3,823
| +19% | +$189K | 0.04% | 377 |
|
|
2021
Q3 | $955K | Buy |
19,826
+1,135
| +6% | +$57.7K | 0.03% | 412 |
|
|
2021
Q2 | $984K | Buy |
18,691
+203
| +1% | +$10.6K | 0.03% | 406 |
|
|
2021
Q1 | $914K | Sell |
18,488
-2,179
| -11% | -$105K | 0.03% | 394 |
|
|
2020
Q4 | $1M | Sell |
20,667
-2,364
| -10% | -$117K | 0.04% | 357 |
|
|
2020
Q3 | $1.16M | Buy |
23,031
+258
| +1% | +$13.3K | 0.05% | 284 |
|
|
2020
Q2 | $1.16M | Sell |
22,773
-2,399
| -10% | -$117K | 0.06% | 270 |
|
|
2020
Q1 | $1.1M | Sell |
25,172
-1,095
| -4% | -$52.4K | 0.07% | 252 |
|
|
2019
Q4 | $1.32M | Buy |
26,267
+1,107
| +4% | +$51.9K | 0.06% | 252 |
|
|
2019
Q3 | $1.17M | Buy |
25,160
+1,060
| +4% | +$45.7K | 0.06% | 270 |
|
|
2019
Q2 | $1.04M | Buy |
24,100
+3,846
| +19% | +$164K | 0.06% | 282 |
|
|
2019
Q1 | $897K | Buy |
20,254
+4,414
| +28% | +$189K | 0.05% | 301 |
|
|
2018
Q4 | $688K | Buy |
15,840
+1,258
| +9% | +$55.5K | 0.04% | 324 |
|
|
2018
Q3 | $651K | Sell |
14,582
-14,952
| -51% | -$639K | 0.04% | 369 |
|
|
2018
Q2 | $1.18M | Buy |
29,534
+742
| +3% | +$29.2K | 0.07% | 245 |
|
|
2018
Q1 | $1.15M | Sell |
28,792
-2,551
| -8% | -$106K | 0.08% | 228 |
|
|
2017
Q4 | $1.35M | Sell |
31,343
-6,144
| -16% | -$283K | 0.09% | 209 |
|
|
2017
Q3 | $1.87M | Sell |
37,487
-8,255
| -18% | -$399K | 0.13% | 168 |
|
|
2017
Q2 | $2.19M | Sell |
45,742
-5,872
| -11% | -$281K | 0.16% | 135 |
|
|
2017
Q1 | $2.34M | Buy |
51,614
+2,702
| +6% | +$115K | 0.18% | 127 |
|
|
2016
Q4 | $1.98M | Sell |
48,912
-5,039
| -9% | -$199K | 0.16% | 141 |
|
|
2016
Q3 | $2.06M | Buy |
53,951
+13,945
| +35% | +$560K | 0.18% | 127 |
|
|
2016
Q2 | $1.68M | Buy |
40,006
+14,978
| +60% | +$614K | 0.15% | 147 |
|
|
2016
Q1 | $1M | Buy |
25,028
+7,191
| +40% | +$289K | 0.09% | 206 |
|
|
2015
Q4 | $760K | Sell |
17,837
-494
| -3% | -$22.7K | 0.07% | 261 |
|
|
2015
Q3 | $870K | Sell |
18,331
-3,899
| -18% | -$199K | 0.1% | 199 |
|
|
2015
Q2 | $1.1M | Sell |
22,230
-1,980
| -8% | -$100K | 0.12% | 182 |
|
|
2015
Q1 | $1.2M | Buy |
24,210
+10,226
| +73% | +$489K | 0.13% | 174 |
|
|
2014
Q4 | $638K | Sell |
13,984
-719
| -5% | -$34.9K | 0.07% | 270 |
|
|
2014
Q3 | $829K | Buy |
14,703
+181
| +1% | +$9.72K | 0.09% | 210 |
|
|
2014
Q2 | $772K | Buy |
14,522
+136
| +0.9% | +$7.22K | 0.09% | 227 |
|
|
2014
Q1 | $752K | Sell |
14,386
-1,938
| -12% | -$98.1K | 0.09% | 215 |
|
|
2013
Q4 | $875K | Sell |
16,324
-14,325
| -47% | -$739K | 0.11% | 184 |
|
|
2013
Q3 | $1.55M | Sell |
30,649
-1,779
| -5% | -$90.5K | 0.24% | 105 |
|
|
2013
Q2 | $1.67M | Buy |
+32,428
| New | +$1.73M | 0.27% | 94 |
|
Other funds holding SNY
Raymond James Trust's SNY Position: Q3 2024 in Review
Raymond James Trust increased its Sanofi (SNY) stake by 4% in Q3 2024, buying an estimated $114K and bringing the position to 55,200 shares worth $3.18M. The position accounts for 0.07% of the portfolio, ranked #235.
Raymond James Trust first reported a position in SNY in Q2 2013 and has held it in 46 quarters since. 756 funds tracked by Wall St. Rank hold SNY as of Q3 2024.
- Raymond James Trust held 55,200 shares of Sanofi worth $3.18M as of Q3 2024.
- Raymond James Trust bought 2,120 Sanofi shares in Q3 2024, an estimated $114K.
- Sanofi made up 0.07% of Raymond James Trust's portfolio in Q3 2024, its #235 holding.
- Raymond James Trust first reported a position in Sanofi in Q2 2013 and has held it in 46 quarters since.
- 756 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.
Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.